These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7048344)

  • 1. [Biopharmaceutical aspects of parenteral drug formulations].
    Pflegel H
    Pharmazie; 1982 Apr; 37(4):307-18. PubMed ID: 7048344
    [No Abstract]   [Full Text] [Related]  

  • 2. Scheele lecture. Biopharmaceutical aspects of drug formulation.
    Davis SS
    Acta Pharm Suec; 1986; 23(5):305-14. PubMed ID: 3565033
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspects of current parenteral formulation.
    Scheindlin S
    Bull Parenter Drug Assoc; 1970; 24(1):31-9. PubMed ID: 5415610
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulation of a parenteral antimalarial solution--a French undergraduate project in industrial pharmacy.
    Jeannin C; Pourcelot Y
    Am J Pharm Educ; 1977 Feb; 41(1):59-61. PubMed ID: 10236632
    [No Abstract]   [Full Text] [Related]  

  • 5. Biopharmaceutics of vitamin A injection.
    Bauernfeind JC; Newmark HL
    Bull Parenter Drug Assoc; 1970; 24(4):169-75. PubMed ID: 5431584
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biopharmaceutical evaluation of preparations intended for the parenteral route].
    Aiache JM; Aiache S
    Boll Chim Farm; 1983 May; 122(5):213-28. PubMed ID: 6357232
    [No Abstract]   [Full Text] [Related]  

  • 7. Biopharmaceutical benchmarks--2003.
    Walsh G
    Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biopharmacy--what is that?].
    Wulff O
    Ugeskr Laeger; 1973 Jul; 135(28):1477-9. PubMed ID: 4757144
    [No Abstract]   [Full Text] [Related]  

  • 9. Particulate matter in parenteral solutions.
    Med Lett Drugs Ther; 1968 May; 10(11):42-4. PubMed ID: 5656614
    [No Abstract]   [Full Text] [Related]  

  • 10. [The foreign particles in injectable solutions].
    Cavatorta L; Pietra E; Allievi R
    Boll Chim Farm; 1969 Aug; 108(8):488-98. PubMed ID: 5354286
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemical changes due to the compounding of parenteral injections. (1)].
    Kosugi T
    Iryo; 1967 Aug; 21(8):960-1. PubMed ID: 5582998
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the feasibility of oral controlled release in an exploratory development setting.
    Thombre AG
    Drug Discov Today; 2005 Sep; 10(17):1159-66. PubMed ID: 16182208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated early formulation strategy--from hit evaluation to preclinical candidate profiling.
    Maas J; Kamm W; Hauck G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):1-10. PubMed ID: 17123801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The availability of antibiotics in combination with other additives in intravenous solutions.
    Dancey JW; Carew DP
    Am J Hosp Pharm; 1966 Oct; 23(10):543-51. PubMed ID: 5915776
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biopharmaceutical aspects of pharmaceutical technology].
    Thoma K
    Pharmazie; 1981 Mar; 36(3):185-93. PubMed ID: 7279982
    [No Abstract]   [Full Text] [Related]  

  • 16. The Resotest Apparatus. A universally applicable biopharmaceutical experimental tool.
    Koch HP
    Methods Find Exp Clin Pharmacol; 1980 Apr; 2(2):97-102. PubMed ID: 7339334
    [No Abstract]   [Full Text] [Related]  

  • 17. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives.
    Breda SA; Jimenez-Kairuz AF; Manzo RH; Olivera ME
    Int J Pharm; 2009 Apr; 371(1-2):106-13. PubMed ID: 19150493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosizing--oral formulation development and biopharmaceutical evaluation.
    Kesisoglou F; Panmai S; Wu Y
    Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new formulation concept for drugs with poor water solubility for parenteral application.
    Jürgens K; Müller BW
    Pharmazie; 2005 Sep; 60(9):665-70. PubMed ID: 16222865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.